Your browser doesn't support javascript.
loading
Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection.
Frigeni, Marco; Besson, Caroline; Visco, Carlo; Fontaine, Helene; Goldaniga, Maria; Visentini, Marcella; Pulsoni, Alessandro; Torres, Harrys A; Peveling-Oberhag, Jan; Rossotti, Roberto; Zaja, Francesco; Rigacci, Luigi; Merli, Michele; Dorival, Céline; Alric, Camille; Piazza, Francesco; Gentile, Massimo; Ferrari, Angela; Pirisi, Mario; Nassi, Luca; Rattotti, Sara; Frustaci, Annamaria; Milella, Michele; Cencini, Emanuele; Defrancesco, Irene; Ferretti, Virginia Valeria; Bruno, Raffaele; Hermine, Olivier; Arcaini, Luca.
Afiliación
  • Frigeni M; Department of Molecular Medicine, University of Pavia, Pavia, Italy.
  • Besson C; Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Visco C; APHP CHU Bicêtre, Université Paris Sud, INSERM U1012, Orsay, France.
  • Fontaine H; Department of Medicine, Section of Hematology, University of Verona, Verona, Italy.
  • Goldaniga M; Department of Hepatology, Inserm U-1213 and UMS-20, Institut Pasteur, Paris 5 Descartes University, Paris, France.
  • Visentini M; Department of Hematology, Fondazione Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milano, Italy.
  • Pulsoni A; Department of Translational and Precision Medicine, Laboratory affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Sapienza University of Rome, Rome, Italy.
  • Torres HA; Division of Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Fondazione Roma, Rome, Italy.
  • Peveling-Oberhag J; Department of Infectious Diseases, Infection Control, and Employee Health, and Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Rossotti R; Department of Internal Medicine 1, Goethe-University Hospital, Frankfurt, Germany.
  • Zaja F; Department of Internal Medicine 1, Robert-Bosch-Krankenhaus, Stuttgart, Germany.
  • Rigacci L; Department of Infectious Diseases, Ospedale Niguarda Ca' Granda, Milano, Italy.
  • Merli M; Hematology Unit, Azienda Sanitaria Universitaria Integrata, Trieste, Italy.
  • Dorival C; Hematology Unit and Bone Marrow Transplant Unit, San Camillo Forlanini Hospital, Rome, Italy.
  • Alric C; Division of Hematology, Ospedale di Circolo e Fondazione Macchi, University of Insubria, Varese, Italy.
  • Piazza F; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, F75012, Paris, France.
  • Gentile M; Hematology Department, Institut Universitaire du Cancer de Toulouse-Oncopole (IUCT-O) Toulouse 3 University, Paris, France.
  • Ferrari A; Hematology and Clincal Immunology Branch, Department of Medecine, University of Padova, Padova, Italy.
  • Pirisi M; Hematology Unit, Department of Onco-Hematology, A.O. of Cosenza, Cosenza, Italy.
  • Nassi L; Division of Hematology, Azienda USL IRCCS Reggio Emilia, Reggio Emilia, Italy.
  • Rattotti S; Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
  • Frustaci A; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
  • Milella M; Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Cencini E; Department of Hematology, Ospedale Niguarda Ca' Granda, Milano, Italy.
  • Defrancesco I; Division of Infectious Diseases, University Hospital Policlinico Consorziale, Bari, Italy.
  • Ferretti VV; Division of Hematology, Azienda Ospedaliera Senese, University of Siena, Siena, Italy.
  • Bruno R; Department of Molecular Medicine, University of Pavia, Pavia, Italy.
  • Hermine O; Department of Molecular Medicine, University of Pavia, Pavia, Italy.
  • Arcaini L; Department of Clinical Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.
Leukemia ; 34(5): 1462-1466, 2020 05.
Article en En | MEDLINE | ID: mdl-31836855

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antivirales / Linfocitos B / Interferón-alfa / Hepatitis C / Hepacivirus / Trastornos Linfoproliferativos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antivirales / Linfocitos B / Interferón-alfa / Hepatitis C / Hepacivirus / Trastornos Linfoproliferativos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Italia